š Josh Bartch is the CEO of Mydecine Innovations Group, a psychedelics company that is researching naturally sourced psychedelic therapeutics targeting PTSD and smoking cessation. Ā In this episode of The Integration Conversation, Josh joins us for a full hour and tells us about Mydecine's clinical trials, its research on functional mushrooms, and makes his pitch for why Mydecine is undervalued relative to its peers. Ā Ā Ā
Questions we answer:Ā
š„ Invest in Psychedelic Startups with Us š„Ā
go to https://theintegration.co and click on "invest in psychedelic startups" Ā
The Integration Conversation is a podcast that covers the emerging psychedelics industry from a business perspective, and aims to be your number 1 resource for investing in psychedelics, Ā psychedelic investing and psychedelic business. Ā
ā All our links: Ā
https://theintegration.coĀ
š My notes on psychedelic investing: Ā
https://brompersonal.s3-us-west-2.amazonaws.com/assets/broms-notes-psychedelic-investing.pdf Ā Ā
š§ Listen on Spotify and other podcast platforms: Ā
https://anchor.fm/theintegrationcoĀ
š¦ brom on twitter: Ā
https://twitter.com/therealbromĀ
š Clips and other stuff on Instagram: Ā
https://instagram.com/theintegrationco Ā
ā° Timestamps:Ā
Disclaimer: This video is not financial advice. Brom holds shares in Mydecine and other psychedelic stocks.
View all episodes
By Brom Rector and Sam Tabone
5
66 ratings
š Josh Bartch is the CEO of Mydecine Innovations Group, a psychedelics company that is researching naturally sourced psychedelic therapeutics targeting PTSD and smoking cessation. Ā In this episode of The Integration Conversation, Josh joins us for a full hour and tells us about Mydecine's clinical trials, its research on functional mushrooms, and makes his pitch for why Mydecine is undervalued relative to its peers. Ā Ā Ā
Questions we answer:Ā
š„ Invest in Psychedelic Startups with Us š„Ā
go to https://theintegration.co and click on "invest in psychedelic startups" Ā
The Integration Conversation is a podcast that covers the emerging psychedelics industry from a business perspective, and aims to be your number 1 resource for investing in psychedelics, Ā psychedelic investing and psychedelic business. Ā
ā All our links: Ā
https://theintegration.coĀ
š My notes on psychedelic investing: Ā
https://brompersonal.s3-us-west-2.amazonaws.com/assets/broms-notes-psychedelic-investing.pdf Ā Ā
š§ Listen on Spotify and other podcast platforms: Ā
https://anchor.fm/theintegrationcoĀ
š¦ brom on twitter: Ā
https://twitter.com/therealbromĀ
š Clips and other stuff on Instagram: Ā
https://instagram.com/theintegrationco Ā
ā° Timestamps:Ā
Disclaimer: This video is not financial advice. Brom holds shares in Mydecine and other psychedelic stocks.
32,073 Listeners
225,496 Listeners
1,795 Listeners
9,265 Listeners
2,287 Listeners
110,824 Listeners
298 Listeners
2,619 Listeners
5,361 Listeners
9,276 Listeners
424 Listeners
51 Listeners
5,437 Listeners
15,363 Listeners
8,609 Listeners